A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Relative Bioavailability of Lesinurad/Allopurinol Fixed Dose Combination Tablets and Coadministered Lesinurad and Allopurinol Tablets and the Effect of Food on the Pharmacokinetics of Lesinurad/Allopurinol Fixed Dose Combination Tablets in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2016
At a glance
- Drugs Allopurinol/lesinurad (Primary) ; Allopurinol; Lesinurad
- Indications Gout
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 29 Aug 2016 Status changed from recruiting to completed.
- 02 Dec 2015 Planned End Date changed from 1 Mar 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 02 Dec 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.